SA COVID-19 vaccines reported to be less-efficient and expire soon
Oxford AstraZeneca vaccines that arrived in South Africa last-week Monday has been reported to be less efficient and expected to expire soon.
Prof Shabir Madhi of Wits University revealed during a briefing that studies were done in the wake of the new variant – known as 501Y.V2 or B.1.351 – showed it was not statistically significantly effective against mild or moderate infection, but that it’s likely effective against “severe disease” caused by Covid-19.
Health Minister, Dr ZwelI Mkhize, confirmed that the AstraZeneca vaccine offered only limited protection against mild and moderate cases of the SA discovered COVID-19 variant. Hence, he temporarily halted the roll out of the 1 million vaccines.
The rollout has been suspended temporarily
— Entrepreneur Zone (@SayEntrepreneur) February 7, 2021
The arrival of the first one million #COVID19 vaccines from the Serum Institute of India was a historic moment for South Africa. Watch a few highlights here: pic.twitter.com/mbpDtZl2El
— Dr Zweli Mkhize (@DrZweliMkhize) February 2, 2021
Janssen Ad26 COVID-19 vaccine showed efficacy in prevention of moderate to severe or critical COVID-19 infection .The vaccine was 57% effective in South Africa, where nearly all of the cases were due to infection with the new variant: Prof Gray#COVID19 pic.twitter.com/COelF73gx8
— SABC News (@SABCNews) February 7, 2021
The post SA COVID-19 vaccines reported to be less-efficient and expire soon appeared first on .